Related Experiment Video
Updated: Jun 3, 2026

Cecal Ligation and Puncture-induced Sepsis as a Model To Study Autophagy in Mice
Published on: February 9, 2014
The autophagy-inhibitory tissue hormone DBI/ACBP contributes to the pathogenesis of multiple organ dysfunction
Flavia Lambertucci1, Maria Chiara Maiuri1,2, Isabelle Martins1
1Université Paris Cité, Sorbonne Université, Inserm U1138, Centre de Recherche des Cordeliers, Team « Metabolism, Cancer & Immunity », Equipe labellisée par la Ligue contre le cancer, Paris, France.
Abstract:
Systemic microbial infection leading to septic shock with multiple organ dysfunction syndrome (MODS) is a major cause of mortality and represents a substantial unmet medical need. We recently observed that, compared with uninfected controls, patients with septic shock exhibit significantly elevated circulating concentrations of the tissue hormone acyl-CoA binding protein (ACBP), encoded by the diazepam binding inhibitor (DBI) gene, a potent inhibitor of autophagy. Increased plasma DBI/ACBP levels correlated with disease severity and poor clinical outcome. Similarly, DBI/ACBP concentrations were elevated in three distinct mouse models of septic shock induced by (i) bacterial lipopolysaccharide injection, (ii) inoculation with monomicrobial Escherichia coli or (iii) polymicrobial sepsis following cecal ligation and puncture. In all three models, neutralization of DBI/ACBP using specific monoclonal antibodies significantly reduced mortality. Comprehensive behavioral, cardiac, pulmonary, hepatic, renal and splenic phenotyping further demonstrated that DBI/ACBP neutralization alleviated all hallmarks of MODS, including impaired thermoregulation, lethargy and organ failure affecting the heart, lungs, liver and kidneys. Multi-omics analyses, including bulk transcriptomics, metabolomics and high-dimensional immunophenotyping, revealed that DBI/ACBP neutralization attenuated sepsis-associated alterations in gene expression, metabolism and myeloid cell infiltration across major organs. Mechanistically, DBI/ACBP inhibition enhanced organ resistance to lipopolysaccharide-induced sterile inflammation while simultaneously promoting bacterial clearance by macrophages and granulocytes both in vivo and in vitro in models of monomicrobial and polymicrobial sepsis. Collectively, these findings identify DBI/ACBP as a pathogenic mediator of sepsis, consistent with its previously described anti-autophagic, immunosuppressive, pro-inflammatory and pro-senescent properties.
Insights
Elevated acyl-CoA binding protein (ACBP), encoded by the diazepam binding inhibitor (DBI) gene, exacerbates septic shock and multiple organ dysfunction syndrome (MODS). Neutralizing DBI/ACBP significantly reduced mortality and alleviated MODS in preclinical models.
Area of Science:
- Immunology
- Pathophysiology
- Molecular Medicine
Background:
- Septic shock and multiple organ dysfunction syndrome (MODS) are leading causes of mortality with limited treatment options.
- Acyl-CoA binding protein (ACBP), encoded by the diazepam binding inhibitor (DBI) gene, is a tissue hormone that inhibits autophagy.
- Elevated circulating DBI/ACBP levels are observed in patients with septic shock and correlate with disease severity.
Purpose of the Study:
- To investigate the role of DBI/ACBP in sepsis pathophysiology.
- To evaluate the therapeutic potential of DBI/ACBP neutralization in preclinical sepsis models.
Main Methods:
- DBI/ACBP levels were measured in patients and mouse models of sepsis.
- Monoclonal antibodies were used to neutralize DBI/ACBP in mouse models.
- Comprehensive phenotyping and multi-omics analyses were performed.
- In vitro and in vivo assays assessed the impact of DBI/ACBP inhibition on inflammation and bacterial clearance.
Main Results:
- DBI/ACBP concentrations were significantly elevated in septic shock patients and mouse models.
- Neutralization of DBI/ACBP reduced mortality and alleviated MODS hallmarks in mice.
- DBI/ACBP inhibition attenuated sepsis-associated molecular and cellular changes.
- DBI/ACBP inhibition enhanced organ resistance to inflammation and promoted bacterial clearance.
Conclusions:
- DBI/ACBP is a pathogenic mediator of sepsis and MODS.
- Neutralizing DBI/ACBP represents a promising therapeutic strategy for sepsis.
Related Concept Videos
Acute Pancreatitis II: Pathophysiology
Acute Inflammation III: Local and Systemic Effects
Diabetic Ketoacidosis ll: Pathophysiology
Inflammatory Bowel Disease III: Crohn's Disease
Bacterial Meningitis II: Pathophysiology
Acute Kidney Injury II: Pathophysiology
